Ποια είναι η τιμή για Vycor Medical, Inc. (VYCO)

Η τιμή για Vycor Medical, Inc. (VYCO) είναι $0.069

Ποια είναι η κεφαλαιοποίηση αγοράς για Vycor Medical, Inc. (VYCO)

Η κεφαλαιοποίηση αγοράς για Vycor Medical, Inc. (VYCO) είναι $2.30M

Vycor Medical, Inc. (VYCO) Κέρδη

Vycor Medical, Inc. (VMI) is dedicated to the creation, development, and commercialization of neurological medical devices and therapeutic solutions, operating in both the United States and European markets. The company's operations are divided into two primary business units. The Vycor Medical division specializes in neurosurgical instrumentation, providing devices such as the ViewSite Brain Access System—a critical retraction and access tool used in brain and spine surgeries. Conversely, the NovaVision segment delivers advanced, non-invasive, computer-based rehabilitation programs aimed at helping individuals with vision impairments resulting from strokes or other brain injuries. VMI has also established a strategic license and transition agreement with HelferApp GmbH, authorizing HelferApp to distribute NovaVision's products and therapies to patients and healthcare providers in Austria and Switzerland. The company's main clientele consists of hospitals and various medical professionals. Established in 2005, Vycor Medical, Inc. is headquartered in Boca Raton, Florida, and functions as a subsidiary of Fountainhead Capital Management Limited.

Έτος	Κέρδη	Αλλαγή
Δεν υπάρχουν αρκετά δεδομένα για τις παρεχόμενες ημερομηνίες.

Έτος

Κέρδη

Αλλαγή

Δεν υπάρχουν αρκετά δεδομένα για τις παρεχόμενες ημερομηνίες.

Εταιρεία	Κέρδη	Διαφορά Κερδών	Χώρα
Abbott Laboratories ABT.US	$7.51B	-	US
Stryker Corporation SYK.US	$5.15B	-	US
Medtronic plc MDT.US	$5.56B	-	IE
Boston Scientific Corporation BSX.US	$3.86B	-	US
Edwards Lifesciences Corporation EW.US	$1.42B	-	US

Εταιρεία

Κέρδη

Διαφορά Κερδών

Χώρα